Karo Pharma postpones the Annual General Meeting to 25 May, 2020
The board of directors of Karo Pharma Aktiebolag (”Karo Pharma”) has resolved to postpone the Annual General Meeting to 25 May, 2020. The previously communicated date for the meeting was 29 April 2020. The delay is due to the increased concern of the spread of COVID-19 with the related safety of the participants. A notice will be sent out four weeks in advance of the meeting.
For additional information, please contact:
Christoffer Lorenzen, CEO, +4673-501 76 20, email@example.com
Jon Johnsson, CFO, +4673-507 88 61, firstname.lastname@example.org
About Karo Pharma
Karo Pharma is a pharmaceutical company specialized in sales and marketing of prescription pharmaceuticals and over-the-counter products sold in pharmacies and retail. Karo Pharma is listed on Nasdaq Stockholm Mid Cap.
The information was submitted for publication, through the agency of the contact persons set out above, at 13.00 CET on 27 March, 2020.